Related Experiment Videos
Pharmacology of drugs that alter multidrug resistance in cancer
1Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Pharmacological Reviews
|September 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A method for estimating and characterizing explicitly nonlinear dynamic functional network connectivity in resting-state fMRI data.
Journal of neuroscience methods·2023
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms.
Psychological medicine·2018
Medication adherence: An overlooked critical determinant of pharmacological effectiveness.
Pharmacological reviews·2026
GPCR signaling from a primary cilium perspective.
Pharmacological reviews·2026
The promise of biased ligands in therapeutics.
Pharmacological reviews·2026
Kv7 channels as pharmacological targets for central nervous system diseases.
Pharmacological reviews·2026
Recombinant protein drug metabolism and pharmacokinetics.
Pharmacological reviews·2026
Calreticulin and myeloproliferative neoplasms: linking biology to targeted therapies.
Expert review of clinical immunology·2026
MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
TRPM4 promotes ErSO-mediated oncosis-like cell death in prostate cancer cells.
Cancer research communications·2026
NEK2 Promotes OSCC Invasion and Metastasis by Activating TNF-α Signaling Through Impairment of Desmosomal Adhesion.
BioFactors (Oxford, England)·2026
Epigenetic modulation of NKG2D ligands enhances NKG2D-CAR T cell efficacy in neuroblastoma.
Journal of translational medicine·2026